AvaGen is a new genetic test that identifies the risk of developing keratoconus and the presence of corneal
With AvaGen, physicians now have access to a new tool to provide a more precise medical consultation to their
patients, especially with at-risk patients, such as those with a family history of genetic eye disease. The
ultimate goal for AvaGen is to help provide patients with a lifetime of healthy eye and vision care.
Visit Universal test or Resource
summary for practice forms.
AvaGen is designed to be easy to interpret. Materials are also available to help explain test results to your
Avellino also provides the services of genetic counselors to assist physicians and patients with added expert
Review a typical sample patient report.
Keratoconus, a corneal ectatic disorder, is a complex disease characterized
by genetic heterogeneity requiring a comprehensive sequencing method able to detect rare DNA variants. Here,
we present a representative case study where a targeted next-generation sequencing (NGS) platform was used to
uncover rare variants.
Check back soon for additional data on variant confirmations in relation to their individual impacts to the
AvaGen will be available in the U.S. in late 2019/early 2020. To support the test, Avellino has created easy-to-use forms
and materials for your practice, including patient support materials. We want to make the test process as
seamless as possible.
For additional materials, visit our Resource Summary page.